Zevra Therapeutics, Inc. (ZVRA) insider trading.
In Q3 2026, insiders at Zevra Therapeutics, Inc. reported 3 non-derivative transactions on 2 Forms 3, 4 and 5: 0 open-market purchases and 2 sales worth $613K.
- Transactions
- 3
- Purchases (P)
- 0
- Sales (S)
- 2
- Net shares, P minus S
- -54,966
- Insiders
- 2
- Last filed
- 2026-08-17
Insiders
| Insider | Relationship | Transactions | Buys | Sales |
|---|---|---|---|---|
| Watton Corey Michael | Director | 2 | 0 | 1 |
| Thompson Rahsaan | Officer · Chief Legal & Compliance | 1 | 0 | 1 |
Transactions
| Date | Insider | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| 2026-08-14 | Thompson Rahsaan | S (D) | 42,666 | $11.13 | 37,569 | Form 4 |
| 2026-08-10 | Watton Corey Michael | M (A) | 12,300 | $4.97 | 14,100 | Form 4 |
| 2026-08-10 | Watton Corey Michael | S (D) | 12,300 | $11.25 | 1,800 | Form 4 |
Transaction codes in this quarter
Get ZVRA insider transactions through the API
curl "https://sec-api.dev/api/v1/insider-transactions?period=2026q3&cik=1434647&limit=100" \
-H "Authorization: Bearer $SEC_API_KEY"Insider trading API guide · ZVRA company page · Zevra Therapeutics, Inc. on SEC.gov
Questions
Are insiders buying or selling Zevra Therapeutics, Inc. (ZVRA)?
In Q3 2026, insiders at Zevra Therapeutics, Inc. reported 3 non-derivative transactions on 2 Forms 3, 4 and 5: 0 open-market purchases and 2 sales worth $613K. Grants, tax withholding and option exercises are counted as transactions but are not purchases or sales.
Where do these Zevra Therapeutics, Inc. insider trades come from?
From the SEC Insider Transactions Data Sets for Q3 2026, which republish the Forms 3, 4 and 5 filed on EDGAR. Each row links to its filing on SEC.gov.
Plain-text version for agents and LLMs: /insider-trading/zvra.md
Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.